BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2363 related articles for article (PubMed ID: 17427556)

  • 1. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.
    Maimone S; Calvaruso V; Pleguezuelo M; Squadrito G; Amaddeo G; Jacobs M; Khanna P; Raimondo G; Dusheiko G
    J Viral Hepat; 2009 Nov; 16(11):769-74. PubMed ID: 19709363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ; Hussain M; Lok AS
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M; Zhou X; Wei L; Qiu S; Zhou T; Li L; Gu X; Luo M; Zheng X
    Virol J; 2007 Sep; 4():93. PubMed ID: 17892580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
    Xu B; Yao G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the correlation among quantification of HBV-DNA and HBeAg, anti-HBe in hepatitis B carriers].
    Dou YL; Cheng XQ; Li YZ; Han JH; Ni AP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):709-11. PubMed ID: 17172114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients.
    Ozdil B; Cosar AM; Akkiz H; Sandikci MU; Kece C
    Arch Virol; 2009; 154(9):1451-5. PubMed ID: 19672557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 119.